Main Article Content
Objective: one of the main problems for the bioimplants is the charge life of the implant. International Neurotechnology Center is working to develop nerve stimulators and charge units.
Material and Methods: A general object of the present invention is to provide an improved method for transmission of stimulating signals to an electrode implanted in the body. The new neuro implant presented here is a fully implantable, externally rechargeable and controlled system.
Results: To overcome the problems encountered with the existing fully implantable neuro implants such as component failure, limited battery life, programming difficulties and high cost, a new system, that is based on fully implanted externally charged and controlled principles, has been developed.
Conclusion: The newly designed neuro implant system, which is patented and has full quality assurance certificates (CE, ISO9001, and ISO13485), appears to be competitive to the presently known neuro implants in terms of quality, safety, reliability, reduction in size and cost.
Shealy CN, Mortimer JT, Reswick J. Electrical inhibition of pain by stimulation of the dorsal column: preliminary clinical reports. Ants Analg 1967; 46: 489-491.
Lynch P, Melujkin T, Wealman A, Swing E. Neuromodulation for post-amputation pain. Interventional Pain Medicine 2013; 11.
Schachter SC. Vagus nerve stimulation therapy summary: five years after FDA approval. Neurology 2002;59:515-520.
George MS, Sackeim HA, Rush AJ. et al. Vagus Nerve Stimulation: A new tool for Brain Research and Therapy. Bill Psychiatry 2000;47:287-295.
Merill CA, Jonsson MAG, Minthon L. et al. Vagus Nerve Stimulation in patients with Alzheimer’s disease: Additional follow-up results of a pilot study through 1 year. J Clin Psychiatry 2006;67:1171-1178.
Krieger LM, Krieger AJ. The intercostal to phrenic nerve transfer: an effective means of reanimating the diaphragm in patients with high cervical spine injury. Plastic and Reconstructive Surgery 2000;105:1255-1261.
SOliven A. Treating obstructive sleep apnea with hypoglossol nerve stimulation. Cur Opin Pulm Med 2011;17:419-424.
Iansek R, Rosenfeld JV, Huxham FE. Deep brain stimulation of the sub thalamic nucleus in Parkinson’s disease. MJ 2002;177:142-146.
Tulgar M, Özyurt ME. New generation neuroimplants. Presented at: International Neuroimplantation Congress, 22-23 January 2010, Istanbul, Turkey.
Tulgar M, Bilgin S, Yıldırım A. The human body’s own language to be considered for safe and effective neurostimulation.